Literature DB >> 6171213

Relationship of the erythrocyte sedimentation rate to acute phase proteins in polymyalgia rheumatica and giant cell arteritis.

J R Park, J G Jones, B L Hazleman.   

Abstract

We have compared the erythrocyte sedimentation rate (ESR) with other acute phase proteins (C-reactive protein (CRP), alpha(1) antitrypsin, orosomucoid, and haptoglobin) in 108 patients with polymyalgia rheumatica and/or giant cell arteritis. There was good correlation between CRP and ESR, but the ESR was also found to have the highest correlation with disease activity. The additional measurement of CRP or other acute phase proteins may be of value in a minority of cases.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6171213      PMCID: PMC1000787          DOI: 10.1136/ard.40.5.493

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  11 in total

1.  OCCULT TEMPORAL ARTERITIS.

Authors:  J F CULLEN
Journal:  Trans Ophthalmol Soc U K       Date:  1963

2.  Erythrocyte sedimentation rate in elderly hospital in-patients.

Authors:  R V Boyd; B I Hoffbrand
Journal:  Br Med J       Date:  1966-04-09

3.  Erythrocyte sedimentation rate and age.

Authors:  G S Hayes; I N Stinson
Journal:  Arch Ophthalmol       Date:  1976-06

4.  Agarose gel electrophoresis.

Authors:  J O Jeppsson; C B Laurell; B Franzén
Journal:  Clin Chem       Date:  1979-04       Impact factor: 8.327

5.  Polymyalgia rheumatica -- a clinical study with particular reference to arterial disease.

Authors:  A G Mowat; B L Hazleman
Journal:  J Rheumatol       Date:  1974-06       Impact factor: 4.666

6.  Observations on temporal arteritis.

Authors:  B Wadman; I Werner
Journal:  Acta Med Scand       Date:  1972-11

7.  Manifestations of giant cell arteritis.

Authors:  L A Healey; K R Wilske
Journal:  Med Clin North Am       Date:  1977-03       Impact factor: 5.456

8.  Intermittent claudication and polymyalgia rheumatica. Association with panarteritis.

Authors:  G G Hunder; S G Sheps
Journal:  Arch Intern Med       Date:  1967-06

9.  Polymyalgia rheumatica. A manifestation of systemic giant-cell arteritis.

Authors:  K R Wilske; L A Healey
Journal:  Ann Intern Med       Date:  1967-01       Impact factor: 25.391

10.  Giant cell arteritis. Clinical features and involvement of different organs.

Authors:  B E Malmvall; B A Bengtsson
Journal:  Scand J Rheumatol       Date:  1978       Impact factor: 3.641

View more
  9 in total

1.  Isolation and analysis of immune complexes from sera of patients with polymyalgia rheumatica and giant cell arteritis.

Authors:  A J Smith; V Kyle; T E Cawston; B L Hazleman
Journal:  Ann Rheum Dis       Date:  1987-06       Impact factor: 19.103

2.  Development of outcome measures for large-vessel vasculitis for use in clinical trials: opportunities, challenges, and research agenda.

Authors:  Haner Direskeneli; Sibel Z Aydin; Tanaz A Kermani; Eric L Matteson; Maarten Boers; Karen Herlyn; Raashid A Luqmani; Tuhina Neogi; Philip Seo; Ravi Suppiah; Gunnar Tomasson; Peter A Merkel
Journal:  J Rheumatol       Date:  2011-07       Impact factor: 4.666

3.  Erythrocyte sedimentation rate and C reactive protein in the assessment of polymyalgia rheumatica/giant cell arteritis on presentation and during follow up.

Authors:  V Kyle; T E Cawston; B L Hazleman
Journal:  Ann Rheum Dis       Date:  1989-08       Impact factor: 19.103

4.  The clinical and laboratory course of polymyalgia rheumatica/giant cell arteritis after the first two months of treatment.

Authors:  V Kyle; B L Hazleman
Journal:  Ann Rheum Dis       Date:  1993-12       Impact factor: 19.103

Review 5.  Polymyalgia rheumatica. Its correct diagnosis and treatment.

Authors:  F D Hart
Journal:  Drugs       Date:  1987-03       Impact factor: 9.546

6.  Plasma viscosity in giant cell arteritis as a predictor of disease activity.

Authors:  M Gudmundsson; E Nordborg; B A Bengtsson; A Bjelle
Journal:  Ann Rheum Dis       Date:  1993-02       Impact factor: 19.103

7.  Polymyalgia rheumatica, temporal arteritis and malignancy.

Authors:  C A Speed; I Haslock
Journal:  Postgrad Med J       Date:  1995-08       Impact factor: 2.401

8.  Severe cardiac failure and leukoerythroblastic anaemia in a patient with giant cell arteritis.

Authors:  R J Unwin; D J Carmichael; W S Peart
Journal:  J R Soc Med       Date:  1988-01       Impact factor: 18.000

9.  Giant cell arteritis versus Takayasu's Arteritis: Two sides of the same coin?

Authors:  Peter W Mortensen; Subahari Raviskanthan; Patricia Chévez-Barrios; Andrew G Lee
Journal:  Saudi J Ophthalmol       Date:  2022-04-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.